Candida Albicans ENO1 Null Mutants Exhibit Altered Drug Susceptibility, Hyphal Formation, and Virulence

Overview

Journal J Microbiol

Specialty Microbiology

Date 2013 Jul 2

PMID 23812815

Citations 25

Authors

Hui-Ching Ko

Ting-Yin Hsiao

Chiung-Tong Chen

Yun-Liang Yang

Affiliations

Soon will be listed here.

Abstract

We previously showed that the expression of ENO1 (enolase) in the fungal pathogen Candida albicans is critical for cell growth. In this study, we investigate the contribution of the ENO1 gene to virulence. We conducted our functional study of ENO1 in C. albicans by constructing an eno1/eno1 null mutant strain in which both ENO1 alleles in the genome were knockouted with the SAT1 flipper cassette that contains the nourseothricin-resistance marker. Although the null mutant failed to grow on synthetic media containing glucose, it was capable of growth on media containing yeast extract, peptone, and non-fermentable carbon sources. The null mutant was more susceptible to certain antifungal drugs. It also exhibited defective hyphal formation, and was avirulent in BALB/c mice.

Citing Articles

and activity of 1,2,3,4,6-O-pentagalloyl-glucose against .

Gao L, Wu H, Feng J, Liu Y, Wang R, Yan L Antimicrob Agents Chemother. 2025; 69(3):e0177524.

PMID: 39853121 PMC: 11881577. DOI: 10.1128/aac.01775-24.

A comparative evaluation of CRISPR-Cas9 allele editing systems in : challenging research in a challenging bug.

Sofras D, Carolus H, Subotic A, Romero C, Ennis C, Hernday A bioRxiv. 2025; .

PMID: 39829791 PMC: 11741338. DOI: 10.1101/2025.01.09.632232.

Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris.

Carolus H, Sofras D, Boccarella G, Jacobs S, Biriukov V, Goossens L Nat Microbiol. 2024; 9(11):2954-2969.

PMID: 39472696 DOI: 10.1038/s41564-024-01811-w.

Molecular cloning, expression, and purification, along with epitope analysis of recombinant enolase proteins (a potential vaccine candidate) from and .

Shukla M, Singh R, Chandley P, Rohatgi S Front Fungal Biol. 2024; 5:1399546.

PMID: 38881582 PMC: 11176544. DOI: 10.3389/ffunb.2024.1399546.

Promising immunotherapeutic targets for treating candidiasis.

Feng Z, Lu H, Jiang Y Front Cell Infect Microbiol. 2024; 14:1339501.

PMID: 38404288 PMC: 10884116. DOI: 10.3389/fcimb.2024.1339501.

References

Tsuneki H, Ishizuka M, Terasawa M, Wu J, Sasaoka T, Kimura I . Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol. 2004; 4:18. PMC: 517497. DOI: 10.1186/1471-2210-4-18. View

Lo H, Wang J, Lin C, Chen C, Hsiao T, Hsu C . Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans. Antimicrob Agents Chemother. 2005; 49(3):1213-5. PMC: 549285. DOI: 10.1128/AAC.49.3.1213-1215.2005. View

Van Der Straeten D, Goodman H, Van Montagu M . Plant enolase: gene structure, expression, and evolution. Plant Cell. 1991; 3(7):719-35. PMC: 160039. DOI: 10.1105/tpc.3.7.719. View

De Backer M, Nelissen B, Logghe M, Viaene J, Loonen I, Vandoninck S . An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans. Nat Biotechnol. 2001; 19(3):235-41. DOI: 10.1038/85677. View

Xin H, Dziadek S, Bundle D, Cutler J . Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A. 2008; 105(36):13526-31. PMC: 2533223. DOI: 10.1073/pnas.0803195105. View

Sundstrom P, Aliaga G . A subset of proteins found in culture supernatants of Candida albicans includes the abundant, immunodominant, glycolytic enzyme enolase. J Infect Dis. 1994; 169(2):452-6. DOI: 10.1093/infdis/169.2.452. View

Sharkey L, Liao W, Ghosh A, Fonzi W . Flanking direct repeats of hisG alter URA3 marker expression at the HWP1 locus of Candida albicans. Microbiology (Reading). 2005; 151(Pt 4):1061-1071. DOI: 10.1099/mic.0.27487-0. View

Baron U, Gossen M, Bujard H . Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 1997; 25(14):2723-9. PMC: 146828. DOI: 10.1093/nar/25.14.2723. View

Sung H, Cho J . Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep. 2008; 41(9):615-25. DOI: 10.5483/bmbrep.2008.41.9.615. View

10.

Mason A, Buckley H, Gorman J . Molecular cloning and characterization of the Candida albicans enolase gene. J Bacteriol. 1993; 175(9):2632-9. PMC: 204565. DOI: 10.1128/jb.175.9.2632-2639.1993. View

11.

Baron U, Schnappinger D, Helbl V, Gossen M, Hillen W, Bujard H . Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci U S A. 1999; 96(3):1013-8. PMC: 15342. DOI: 10.1073/pnas.96.3.1013. View

12.

Chen C, Yang Y, Tseng K, Shih H, Liou C, Lin C . Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans. Fungal Genet Biol. 2009; 46(9):714-20. DOI: 10.1016/j.fgb.2009.06.003. View

13.

Chibana H, Uno J, Cho T, Mikami Y . Mutation in IRO1 tightly linked with URA3 gene reduces virulence of Candida albicans. Microbiol Immunol. 2005; 49(10):937-9. DOI: 10.1111/j.1348-0421.2005.tb03686.x. View

14.

Plow E, Freaney D, Plescia J, Miles L . The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol. 1986; 103(6 Pt 1):2411-20. PMC: 2114571. DOI: 10.1083/jcb.103.6.2411. View

15.

Jong A, Chen S, Stins M, Kim K, Tuan T, Huang S . Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells. J Med Microbiol. 2003; 52(Pt 8):615-622. DOI: 10.1099/jmm.0.05060-0. View

16.

Pitarch A, Abian J, Carrascal M, Sanchez M, Nombela C, Gil C . Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics. 2004; 4(10):3084-106. DOI: 10.1002/pmic.200400903. View

17.

Montagnoli C, Sandini S, Bacci A, Romani L, La Valle R . Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med Mycol. 2004; 42(4):319-24. DOI: 10.1080/13693780310001644653. View

18.

McAlister L, Holland M . Targeted deletion of a yeast enolase structural gene. Identification and isolation of yeast enolase isozymes. J Biol Chem. 1982; 257(12):7181-8. View

19.

Arguelles J, Rodriguez T . Trehalose hydrolysis is not required for human serum-induced dimorphic transition in Candida albicans: evidence from a tps1/tps1 mutant deficient in trehalose synthesis. Res Microbiol. 1999; 150(8):521-9. DOI: 10.1016/s0923-2508(99)00105-9. View

20.

Nakayama H, Mio T, Nagahashi S, Kokado M, Arisawa M, Aoki Y . Tetracycline-regulatable system to tightly control gene expression in the pathogenic fungus Candida albicans. Infect Immun. 2000; 68(12):6712-9. PMC: 97771. DOI: 10.1128/IAI.68.12.6712-6719.2000. View